Gujarat Kidney and Super Speciality Ltd - Financial Result for the Quarter ended 30th Sep'26
Gujarat Kidney and Super Speciality Ltd · Outcome · 05 Nov 2026, 12:08 am
Gujarat Kidney and Super Speciality Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lacs) ■ Revenue: 3,809 (+194.6% YoY | +11.1% QoQ) ■ EBITDA: 1,022 (+99.4% YoY | +22.0% QoQ) ■ EBITDA Margin (%): 26.8 (-1281 bps YoY | +239 bps QoQ) ■ PAT: 584 (+118.9% YoY | +12.7% QoQ) ■ EPS (INR): 0.74 (+42.3% YoY | +12.1% QoQ)
Original exchange filing (PDF)
More announcements from Gujarat Kidney and Super Speciality Ltd
- Transcript of Earning Call conducted on 05/11/2026 · 11 Nov 2026
- Audio recording of earning call · 05 Nov 2026
- Revised presentation Uploaded for today''s Earning Con-Call. · 05 Nov 2026
- Investor Presentation for scheduled Conference Call on November 05, 2026 · 05 Nov 2026
- Statement of Deviation and Variation submitted for the quarter ended on September 30, 2026. · 05 Nov 2026
- Monitoring Report for the Quarter ended September 30, 2026 · 05 Nov 2026
- Unaudited Standalone and Consolidated Financial Results for the Quarter ended September 30, 2026 · 05 Nov 2026
- Earning Con-call · 05 Nov 2026
